肺动脉高压患者血清与肺组织尿酸水平研究
该研究在法国肺动脉高压网络中测定特发性、遗传性或食欲抑制剂相关PAH患者基线与首次再评估时的血清尿酸水平,发现首次随访时高尿酸血症与不良预后相关,且尿酸生成酶XO与转运体URATv1在重构肺动脉壁中上调,提示尿酸代谢参与肺血管重构但高尿酸血症本身不加重动物PH。
要点
- 首次随访时高血清尿酸与PAH不良预后相关,基线尿酸无此关联。
- 特发性PAH患者及MCT、SuHx大鼠重构肺动脉壁中XO和URATv1表达上调。
- 高尿酸浓度仅轻度促进特发性PAH患者PA-SMCs生长,对对照细胞无影响。
核心结论
- 特发性PAH患者尿酸水平与受损的临床和血流动力学特征相关,可作为随访中无创预后指标。
- 实验和人类PAH重构肺血管壁中尿酸代谢均发生紊乱。
研究设计与样本
- 在法国肺动脉高压网络中测定特发性、遗传性或食欲抑制剂相关PAH患者基线与首次再评估时的血清尿酸水平。
- 检测对照与PAH患者肺组织及MCT和SuHx大鼠肺组织中XO和URATv1蛋白水平。
- 使用人肺动脉平滑肌细胞和两种肺动脉高压动物模型进行功能研究。
主要发现
- 首次随访时高血清尿酸水平与不良预后相关,基线时无此关联。
- XO和URATv1在特发性PAH患者及MCT和SuHx大鼠重构肺动脉壁中上调。
- 高尿酸浓度轻度促进特发性PAH患者PA-SMCs生长,但不促进对照PA-SMCs生长。
- 氧嗪酸诱导的高尿酸血症未加重MCT诱导的大鼠肺动脉高压。
- 苯溴马隆慢性治疗轻度减轻MCT和SuHx大鼠的肺血管重构。
临床怎么用
- 随访中监测特发性PAH患者血清尿酸水平可能有助于无创评估临床预后。
- 尿酸代谢通路(XO、URATv1)在重构肺血管壁中上调,但降尿酸治疗对PAH的临床获益尚需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Previous studies have suggested an association between uric acid (UA) and the severity of pulmonary arterial hypertension (PAH), but it is unknown whether UA contributes to disease pathogenesis.The aim of this study was to determine the prognostic value of circulating UA in the era of current management of PAH and to investigate the role of UA in pulmonary vascular remodelling.Serum UA levels were determined in idiopathic, heritable or anorexigen PAH at baseline and first re-evaluation in the French Pulmonary Hypertension Network. We studied protein levels of xanthine oxidase (XO) and the voltage-driven urate transporter 1 (URATv1) in lungs of control and PAH patients and of monocrotaline (MCT) and Sugen/hypoxia (SuHx) rats. Functional studies were performed using human pulmonary artery smooth muscle cells (PA-SMCs) and two animal models of pulmonary hypertension (PH).High serum UA levels at first follow-up, but not at baseline, were associated with a poor prognosis. Both the generating enzyme XO and URATv1 were upregulated in the wall of remodelled pulmonary arteries in idiopathic PAH patients and MCT and SuHx rats. High UA concentrations promoted a mild increase in cell growth in idiopathic PAH PA-SMCs, but not in control PA-SMCs. Consistent with these observations, oxonic acid-induced hyperuricaemia did not aggravate MCT-induced PH in rats. Finally, chronic treatment of MCT and SuHx rats with benzbromarone mildly attenuated pulmonary vascular remodelling.UA levels in idiopathic PAH patients were associated with an impaired clinical and haemodynamic profile and might be used as a non-invasive indicator of clinical prognosis during follow-up. Our findings also indicate that UA metabolism is disturbed in remodelled pulmonary vascular walls in both experimental and human PAH.
引用
- Savale L, Akagi S, Tu L, et al. Serum and pulmonary uric acid in pulmonary arterial hypertension. Eur Respir J. 2021. PMID: 33446602. doi:10.1183/13993003.00332-2020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。